Biblio Discovery — Demo Discovery Service

740 results

Showing 1–20 · 0.74 seconds · RSS

Journal

mAbs

Scopus

ISSN 1942-0870 · Taylor & Francis Group · 740 articles in the index

  1. Journal Article

    Expanding the horizons of cancer therapy with next-generation 4-1BB agonists: a review of molecular and clinical strategies to maximize efficacy and ensure safety

    Gihoon You; Jungwoo Choi; Chorong Yang et al.

    mAbs, Vol. 18 No. 1 · 2026 · English · DOAJ Scopus

    Driven by the substantial limitations of first generation 4–1BB agonists urelumab and utomilumab, the field has shifted toward engineering next-generation molecules with improved therapeutic windows. This review provides a comprehensive analysis of this evolution, detailing how key molecular design…

  2. Journal Article

    Alpseq: an open-source workflow to turbocharge nanobody discovery with high-throughput sequencing

    Kathleen Zeglinski; Jakob Schuster; Jaison D Sa et al.

    mAbs, Vol. 18 No. 1 · 2026 · English · DOAJ Scopus

    Nanobodies have emerged as promising tools for many biotechnological applications due to their small size, high stability and remarkable binding specificity. Next-Generation Sequencing (NGS) enables deep profiling of large nanobody libraries and panning campaigns; however, the scale and diversity…

  3. Journal Article

    Dual agonism and selective T-cell depletion activity of a PD-1-directed antibody for treating autoimmune diseases

    Wenbo Jiang; Lingyun Li; Weili Xue et al.

    mAbs, Vol. 18 No. 1 · 2026 · English · DOAJ Scopus

    Precise inhibition of autoreactivity without concomitant induction of general immunosuppression is an overarching goal that remains elusive for the treatment of autoimmune diseases. PD-1 is preferentially expressed on activated T cells that drive autoimmunity. These PD-1+ T cells could serve as a…

  4. Journal Article

    Targeted dual selection to optimize transposon stable pool generation of multispecifics

    Julie Johnston; Sonja Tierson; Yuyan Xu et al.

    mAbs, Vol. 18 No. 1 · 2026 · English · DOAJ Scopus

    Growing knowledge around disease states has led to opportunities within research to make designer molecules with improved specificity and broader efficacy. These next-generation molecules frequently take advantage of multispecific targeting and controlled mechanisms of action by utilizing four…

  5. Journal Article

    P329G-engager: a universal mix & match antibody-based adaptor platform for cancer immunotherapy

    Marlena Surowka; Diana Darowski; Idil Hutter-Karakoc et al.

    mAbs, Vol. 18 No. 1 · 2026 · English · DOAJ Scopus

    Targeting various combinations of tumor antigens and immune cell receptors is of increasing importance in antibody-based cancer immunotherapy. Here, we present a novel modular P329G-engager platform that enables rapid combination of primary tumor-targeting and secondary immune effector antibodies…

  6. Journal Article

    Fine-tuning affinity and spacer design enhances T cell potency in DLL3 and BCMA CAR T cells

    Nicholas Mazzanti; Ninkka Tamot; Andrea Francese et al.

    mAbs, Vol. 18 No. 1 · 2026 · English · DOAJ Scopus

    Chimeric antigen receptor (CAR)-modified T cells have garnered substantial attention due to their clinical success, culminating in six Food and Drug Administration-approved therapies for hematological malignancies. Notably, CD19-specific CAR T cell therapies have achieved remarkable clinical…

  7. Journal Article

    Rapid expression of therapeutic antibodies in mammalian cells via mRNA transfection

    Thornwit Chavalparit; Craig Barry; Helen Gunter et al.

    mAbs, Vol. 18 No. 1 · 2026 · English · DOAJ Scopus

    Messenger RNA (mRNA) has emerged as a powerful tool for protein expression in clinical settings, yet its potential as a platform for biologics manufacturing remains underexplored. Here, we evaluate transient mRNA transfection in Chinese hamster ovary (CHO) cells as a rapid and versatile system for…

  8. Journal Article

    Beyond sequence similarity: ML-powered identification of pHLA off-targets for TCR-mimic antibodies using high throughput binding kinetics

    Alexander Sinclair; Stefan Krämer; Christoph Reinhart et al.

    mAbs, Vol. 18 No. 1 · 2026 · English · DOAJ Scopus

    T-cell receptor mimic (TCRm) antibodies are an emerging class of tumor-targeting agents used in advanced immunotherapies such as bispecific T-cell engagers and CAR-T cells. Unlike conventional antibodies, TCRms are designed to recognize peptide – human leukocyte antigen (pHLA) complexes that…

  9. Journal Article

    Correction

    mAbs, Vol. 18 No. 1 · 2026 · English · DOAJ Scopus

  10. Journal Article

    2025 Ginkgo Datapoints Antibody Developability Competition outcomes: limited model performance and a call for data standardization

    Lood van Niekerk; Joshua Moller; Seth Ritter et al.

    mAbs, Vol. 18 No. 1 · 2026 · English · DOAJ Scopus

    The Ginkgo Datapoints Antibody Developability (AbDev) Competition, a blinded benchmark for developability prediction characterized entirely on a single, industrial-scale experimental platform, was conducted from September 8 to November 18, 2025. We benchmarked predictors across five biophysical…

  11. Journal Article

    A cell line development vector strategy for improved expression of a trispecific T-cell engager in CHO

    Rajesh K. Mistry; Chendi Niu; Giulia Lambiase et al.

    mAbs, Vol. 18 No. 1 · 2026 · English · DOAJ Scopus

    Recent advances in trispecific antibody (trisAb) engineering offer great therapeutic potential, but achieving high product yield and quality in cell line development remains a challenge due to complex chain pairing requirements in production cell lines. In this study, three distinct expression…

  12. Journal Article

    Using mass spectrometry for robust identity release testing in a global quality control network

    Sebastien Leibe; Sebastien Violini; Moritz Vollrath et al.

    mAbs, Vol. 18 No. 1 · 2026 · English · DOAJ Scopus

    Product identity (ID) testing is a fundamental requirement in pharmaceutical quality control. Roche/Genentech has developed and established a mass spectrometry-based platform ID method for routine release testing of biologics in the global clinical and commercial quality control environment. The…

  13. Journal Article

    Rapid and selective characterization of antibody-drug conjugates in complex sample matrices by native affinity liquid chromatography-mass spectrometry

    Dan Bach Kristensen; Nanna Sofie Eskesen; Clara Coll-Satue et al.

    mAbs, Vol. 18 No. 1 · 2026 · English · DOAJ Scopus

    Antibody-drug conjugates (ADCs) and other biopharmaceuticals require robust analytical methods to assess biotransformation in biological matrices. Current approaches often require off-line enrichment and extensive chromatographic separation, limiting throughput and complicating data processing. We…

  14. Journal Article

    RASP: rapid antibody functional screening by pentavalent phage display

    Manpreet Kaur; Abhishek Dubey; Kartik Chandran

    mAbs, Vol. 18 No. 1 · 2026 · English · DOAJ Scopus

    The heavy-chain antibody variable domain (VHH) is the smallest antigen-binding domain of such antibodies, which are derived from camelids. In the past three decades, VHHs, which are also called single-domain antibodies, have been extensively used to target pathogens and/or toxins. Conventional…

  15. Journal Article

    ASD: antigen-specific antibody database

    Arkadiusz Czerwiński; Paweł Dudzic; Konrad Wójtowicz et al.

    mAbs, Vol. 18 No. 1 · 2026 · English · DOAJ Scopus

    The development of computational models addressing therapeutic antibodies faces significant challenges. Particularly, the prediction of binding affinity across a diverse set of measurements, due to the scarcity of data. A critical data element is the set of antibody–antigen interaction pairs…

  16. Journal Article

    Balancing the extremes for antibody developability: hydrophobic and electrostatic germline framework signatures for CDR-loop compensation

    Vera A. Spanke; Valentin J. Egger-Hoerschinger; Clarissa A. Seidler et al.

    mAbs, Vol. 18 No. 1 · 2026 · English · DOAJ Scopus

    Antibody therapeutics are a rapidly growing class of biopharmaceuticals, but concerns regarding potential developability issues persist. While complementarity-determining region (CDR) loops are imperative for antigen specificity and mutations are challenging, the framework regions can be exchanged…

  17. Journal Article

    Overcoming claudin family homology: discovery of ARC101, a highly potent CLDN6-specific T-cell engager with a novel CD3 binder for ovarian adenocarcinoma

    Danlin Yang; Neha Kamran; Gururaj Shivange et al.

    mAbs, Vol. 18 No. 1 · 2026 · English · DOAJ Scopus

    Claudin-6 (CLDN6) is an oncofetal tight junction protein with minimal to no expression in healthy adult tissues but aberrant upregulation in ovarian malignancies, making it an attractive tumor-selective antigen for T cell-based immunotherapy. The development of CLDN6-targeting antibodies, however…

  18. Journal Article

    Near pan-alphavirus neutralization by an antibody-nanobody bispecific

    Sergei Pletnev; Christina L. Gardner; Matthew S. Sutton et al.

    mAbs, Vol. 18 No. 1 · 2026 · English · DOAJ Scopus

    Alphaviruses represent a global concern, with some such as chikungunya virus currently infecting thousands in China and others such as Venezuelan equine encephalitis virus inducing neurological symptoms in 4–14% of infected individuals. A single antibody capable of protecting from all…

  19. Journal Article

    Predicting non-specific binding of VHHs using machine learning models with cluster-aware validation

    Valentin Stanev; Federico Devalle; Mehdi Boroumand et al.

    mAbs, Vol. 18 No. 1 · 2026 · English · DOAJ Scopus

    Propensity for nonspecific binding—also known as polyreactivity—is a serious developability risk factor for biotherapeutic candidates. To minimize this risk, drug companies are increasingly relying on in silico tools utilizing machine learning methods, but developing these tools is challenging. For…